Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …
Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

